Company research
G Medical Innovations Holdings Ltd.
CIK 1760764Updated Sep 29, 2026
GMVDF price & chart
Loading TradingView…
OTC:GMVDF on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Profit or LossUSD | -25,066,000Source | — | — |
| Additional Financial Items | |||
| AdjustmentsForCurrentTaxOfPriorPeriodUSD | — | -3,000Source | -18,000Source |
| AdjustmentsForDecreaseIncreaseInTradeAccountReceivableUSD | 86,000Source | 210,000Source | -161,000Source |
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableUSD | 2,323,000Source | -1,736,000Source | 739,000Source |
| AdjustmentsForSharebasedPaymentsUSD | 12,488,000Source | 648,000Source | 2,872,000Source |
| GeneralAndAdministrativeExpenseUSD | 11,656,000Source | 4,106,000Source | 3,254,000Source |
| IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesUSD | 16,000Source | — | — |
| InterestPaidClassifiedAsFinancingActivitiesUSD | 4,000Source | 143,000Source | 557,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | 366,000Source | 357,000Source | 529,000Source |
| ProceedsFromIssuingSharesUSD | 3,442,000Source | 13,417,000Source | 8,992,000Source |
| ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivitiesUSD | 33,000Source | 66,000Source | — |
| RepaymentsOfBorrowingsClassifiedAsFinancingActivitiesUSD | 5,921,000Source | 536,000Source | 3,967,000Source |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Cost of Goods and Services Sold | — | — | — |
| Selling, General and Administrative ExpenseUSD | 20,605,000Source | 11,091,000Source | 11,652,000Source |
| Total RevenueUSD | 4,420,000Source | 5,058,000Source | 4,900,000Source |
| Additional Financial Items | |||
| ApplicableTaxRatenumber | 0Source | 0Source | 0Source |
| BasicEarningsLossPerShareUSD per share | -34.17Source | -1.3Source | -1.7Source |
| CurrentTaxExpenseIncomeUSD | 16,000Source | 2,000Source | — |
| DeferredTaxExpenseIncomeUSD | 16,000Source | -3,000Source | -18,000Source |
| DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossUSD | 454,000Source | 324,000Source | — |
| DepreciationAndAmortisationExpenseUSD | 667,000Source | 747,000Source | 1,161,000Source |
| DepreciationRightofuseAssetsUSD | 454,000Source | 324,000Source | — |
| DilutedEarningsLossPerShareUSD per share | -34.17Source | -1.3Source | -1.7Source |
| ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilitiesUSD | 366,000Source | 357,000Source | — |
| FinanceCostsUSD | 9,375,000Source | 4,492,000Source | 750,000Source |
| FinanceIncomeUSD | 17,546,000Source | 870,000Source | 344,000Source |
| GeneralAndAdministrativeExpenseUSD | 11,656,000Source | 4,106,000Source | 3,254,000Source |
| GrossProfitUSD | 784,000Source | 1,502,000Source | 667,000Source |
| IncomeTaxExpenseContinuingOperationsUSD | 16,000Source | -3,000Source | -18,000Source |
| InterestExpenseOnLeaseLiabilitiesUSD | 67,000Source | 8,000Source | — |
| OtherIncomeUSD | — | 220,000Source | 227,000Source |
| OtherOperatingIncomeExpenseUSD | 2,031,000Source | 1,246,000Source | 1,118,000Source |
| ProfitLossAttributableToNoncontrollingInterestsUSD | 437,000Source | 130,000Source | 152,000Source |
| ProfitLossAttributableToOwnersOfParentUSD | -25,066,000Source | -14,888,000Source | -12,688,000Source |
| ProfitLossBeforeTaxUSD | -13,942,000Source | -14,891,000Source | -12,706,000Source |
| ProfitLossFromOperatingActivitiesUSD | -22,113,000Source | -11,269,000Source | -12,300,000Source |
| ResearchAndDevelopmentExpenseUSD | 2,292,000Source | 1,680,000Source | 1,315,000Source |